Mesoblast
MESO
18 hedge funds and large institutions have $13.6M invested in Mesoblast in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
13% more funds holding
Funds holding: 16 → 18 (+2)
0.03% less ownership
Funds ownership: 0.3% → 0.27% (-0.03%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
32% less capital invested
Capital invested by funds: $20.1M → $13.6M (-$6.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$188K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$164K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
+$91.9K |
| 4 |
Jane Street
New York
|
+$79.5K |
| 5 |
Morgan Stanley
New York
|
+$6.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$674K |
| 2 |
PCMI
Princeton Capital Management Inc
Princeton,
New Jersey
|
-$148K |
| 3 |
PP
Prudential plc
London, England,
United Kingdom
|
-$42.5K |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.5K |
MESO Hedge Fund Activity: Q3 2017 in Review
18 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2017, worth a combined $13.6M — down 32% from $20.1M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MESO positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $188K. The largest seller was Goldman Sachs, cutting an estimated $674K.
- 18 institutional investors held Mesoblast (MESO) as of Q3 2017, up from 16 in Q2 2017.
- Funds reported $13.6M of Mesoblast stock for Q3 2017, down 32% quarter-over-quarter.
- 3 funds opened new Mesoblast positions in Q3 2017 and 1 closed out, a net change of +2 holders.
- The largest Mesoblast buyer in Q3 2017 was Renaissance Technologies, an estimated $188K added.
- The largest Mesoblast seller in Q3 2017 was Goldman Sachs, an estimated $674K sold.
Based on aggregated 13F filings for Q3 2017.